Attenuation of ischemic liver injury by augmentation of endogenous adenosine

Transplantation

Volumn 63, Issue 2, 1997, Pages 217-223

  Todo, Satoru ^a,b   Zhu, Yue ^a   Zhang, Shimin ^a   Jin, Maeng Bong ^a   Ishizaki, Naoki ^a   Tanaka, Hiromu ^a   Subbotin, Vladimir ^a   Starzl, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DRAFLAZINE; NUCLEOSIDE TRANSPORT INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOG; DRUG MECHANISM; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; LIVER BLOOD FLOW; LIVER FUNCTION TEST; LIVER ISCHEMIA; LIVER TRANSPLANTATION; NONHUMAN; NUCLEOSIDE TRANSPORT; ORGAN PRESERVATION; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0030999823     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199701270-00007     Document Type: Article

References (46)

1. Casavilla A, Ramirez C, Shapiro R, et al. Experience with liver and kidney allografts from non-heartbeating donors. Transplantation 1995; 59: 197.
2. Pichlmayr R, Ringe B, Gubernatis G, Hauss J, Bunzendahl H. Transplantation einer Spenderleber auf zwei Empfanger (Splitting-Transplantation) - Eine neue Methode in der Weiterentwicklung der Lebersegmenttransplantation. Langenbecks Arch Chir 1988; 373: 127.
3. Yamaoka Y, Morimoto T, Inamoto T, et al. Safety of the donor in living-related liver transplantation - an analysis of 100 parental donors. Transplantation 1995; 59: 224.
4. Starzl TE, Fung J, Tzakis A, et al. Baboon to human liver transplantation. Lancet 1993; 341: 65.
5. McKie LD, Bass BL, Dunkin BJ, Harmon JW. Nitric oxide mediates the blood flow response to intravenous adenosine in the rabbit. Circulatory Shock 1994; 43: 103.
6. Ward PA, Cunningham TW, McCulloch KK, Johnson KJ. Regulatory effects of adenosine and adenine nucleotides on oxygen radical responses of neutrophils. Lab Invest 1988; 58: 438.
7. Kitakaze M, Hori M, Sato H, Takashima S, Inoue M, Kitabatake A, Kamada T. Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs. Circ Res 1991; 69: 1402.
8. De La Harpe J, Nathan CF. Adenosine regulates the respiratory burst of cytokine-triggered human neutrophils adherent to biologic surfaces. J Immunol 1989; 143: 596.
9. Wollner A, Wollner S, Smith JB. Acting via A2 receptors, adenosine inhibits the upregulation of Mac-1 (CD11b/CD18) expression on FMLP-stimulated neutrophils. Am J Respir Cell Mol Biol 1993; 9: 179.
10. Mullane K, Bullough D. Harnessing an endogenous cardioprotective mechanism: Cellular sources and sites of action of adenosine. J Mol Cell Cardiol 1995; 27: 1041.
11. Yagi K. A simple flurometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15: 212.
12. Hamamoto I, Takaya S, Todo S, et al. Can adenine nucleotides predict primary nonfunction of the human liver homograft? Transplant Int 1994; 7: 89.
13. Atkinson DE. The energy charge of the adenylate pool as a regulatory parameter, interaction with feed back modifiers. Biochemistry 1968; 7: 4030.
14. Stevens A. Enzyme histochemistry: diagnostic applications. In: Bancroft JD, Stevens A, eds. Theory and practice of histologic techniques. New York: Churchill Livingstone, 1990: 401.
15. Drury AN, Szent-György A. The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J Physiol (Lond) 1929; 68: 213.
16. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124.
17. Jenkins DP, Baxter GF, Yellon DM. The pathophysiology of ischemic preconditioning. Pharmacol Res 1995; 31: 219.
18. Jacobson KA, Trivedi BK, Churchill PC, Williams M. Novel therapeutics acting via purine receptors. Biochem Pharmacol 1991; 41: 1399.
19. Cason BA, Gordon HJ, Avery EG, Hickey RF. The role of ATP sensitive postassium channels in myocardial protection. J Cardiac Surg 1995; 10: 441.
20. De Jonge HW, Van Heugten HA, Lamers JM. Signal transduction by the phosphatidylinositol cycle in myocardium. J Mol Cell Cardiol 1995; 27: 93.
21. Babbitt DG, Virmani R, Forman MB. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. Circulation 1989; 80: 1388.
22. Norton ED, Jackson EK, Virmani R, Forman MB. Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial blood flow. Am Heart J 1991; 122: 1283.
23. Velasco CE, Jackson EK, Morrow JA, Vitola JV, Inagami T, Forman MB. Intravenous adenosine suppresses cardiac release of endothelin after myocardial ischemia and reperfusion. Cardiovasc Res 1993; 27: 121.
24. Kolassa N, Pfleger K. Adenosine uptake by erythrocytes of man, rat, and guinea pig and its inhibition by hexobendine and dipyridamole. Biochem Pharmacol 1975; 24: 154.
25. Van Belle H. Differential inactivation of adenosine by human and canine blood. FEBS Lett 1969; 3: 133.
26. Van Belle H. Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine? Cardiovasc Res 1993; 27: 68.
27. Sandhu GS, Burrier AC, Janero DR. Adenosine deaminase inhibitors attenuate ischemic injury and preserve energy balance in isolated guinea pig heart. Am J Physiol 1993; 265: H1249.
28. Galinanes M, Mullane KM, Bullough D, Hearse DJ. Acadesine and myocardial protection: studies of time of administration and dose-response relations in the rat. Circulation 1992; 86: 598.
29. Masuda M, Chang-Chun C, Mollhoff T, Van Belle H, Flameng W. Effects of nucleoside transport inhibition on long-term ex vivo preservation of canine hearts. J Thorac Cardiovasc Surg 1992; 104: 1610.
30. Masuda M, Demeulemeester A, Chang-Chun C, Hendrikx M, Van Belle H, Flameng W. Cardioprotective effects of nucleoside transport inhibition in rabbit hearts. Ann Thorac Surg 1991; 52: 1300.
31. Flameng W, Sukehiro S, Mollhoff T, Van Belle H, Janssen P. A new concept of long-term donor heart preservation: nucleoside transport inhibition. J Heart Lung Transplant 1991; 10: 990.
32. Booster MH, Yin M, Maessen JG, Stubenitsky BM, Wijnen RM, Kootstra G. Protection of canine renal grafts by renin-angiotensin inhibition through nucleoside transport blockade. Transplant Int 1995; 8: 207.
33. Van Belle H, Goossens F, Wynants J. Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. Am J Physiol 1987; 252: H886.
34. Van Belle H, Wynants J, Xhonneux R, Flameng W. Changes in creatine phosphate, inorganic phosphate, and the purine pattern in dog hearts with time of coronary artery occlusion and effect thereon of mioflazine, a nucleoside transport inhibitor. Cardiovasc Res 1986; 20: 658.
35. Nees S. The adenosine hypothesis of metabolic regulation of coronary flow in the light of newly recognized properties of the coronary endothelium. Z Kardiol 1989; 78: 42.
36. Bontemps F, Vincent MF, Van Den Berghe G. Mechanisms of elevation of adenosine levels in anoxic hepatocytes. Biochem J 1993; 290: 671.
37. Palombo JD, Pomposelli JJ, Fechner KD, Blackburn GL, Bistrian BR. Enhanced restoration of adenine nucleotides in rat liver following extended preservation in UW solution by provision of adenosine during reperfusion. Transplantation 1991; 51: 867.
38. Wiezorek JS, Brown DH, Kupperman DE, Brass CA. Rapid conversion to high xanthine oxidase activity in viable Kupffer cells during hypoxia. J Clin Invest 1994; 94: 2224.
39. Angermuller S, Schunk M, Kusterer K. Alteration of xanthine oxidase activity in sinusoidal endothelial cells and morphological changes of Kupffer cells in hypoxic and reoxygenated rat liver. Hepatology 1995; 21: 1594.
40. Koo A, Komatsu H, Tao G, Inoue M, Guth PH, Kaplowitz N. Contribution of no-reflow phenomenon to hepatic injury after ischemia-reperfusion: evidence for a role for superoxide anion. Hepatology 1991; 15: 507.
41. Gao, Hijioka T, Lindert KA, Caldwell-Kenkel JC, Lemasters JJ, Thurman RG. Evidence that adenosine is a key component in Carolina rinse responsible for reducing graft failure after orthotopic liver transplantation in the rat. Transplantation 1991; 52: 992.
42. Bonnes-Taourel D, Guerin MC, Torreilles J. Is malonaldehyde a valuable indicator of lipid peroxidation? Biochem Pharmacol 1992; 44: 985.
43. Walsh TR, Rao PN, Makowka L, et al. Lipid peroxidation is a nonparenchymal cell event with reperfusion after prolonged liver ischemia. J Surg Res 1990; 49: 18.
44. Daemen JWHG, de Wit RJ, Heineman E, Kootstra G. Kidney transplantation from non-heartbeating donors. Transplant Rev 1995; 9: 159.
45. Flameng W, Sukehiro S, Mollhoff T, Van Belle H, Janssen P. A new concept of long-term donor heart preservation: nucleoside transport inhibition. J Heart Lung Transplant 1991; 10: 990.
46. Mollhoff T, Sukehiro S, Van Belle H, Van Aken H, Flameng W. Successful transplantation after long-term preservation of dog hearts. Anesthesiology 1992; 77: 291.